2012 annual financial data
Alaunos Therapeutics 2012 Operating margin
Alaunos Therapeutics 2012 operating margin with verified reported values.
Direct answer
Operating margin was -12,771.13%.
Operating income was -102,169,000 USD and net income was -96,132,000 USD.
Operating cash flow was -78,832,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 800,000 USD
- Operating income
- -102,169,000 USD
- Net income
- -96,132,000 USD
- Operating cash flow
- -78,832,000 USD